"Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better ...

Cross Country Healthcare (NASDAQ: CCRN), a leader in workforce solutions and tech-enabled staffing, recruitment and advisory services, today released its fourth annual survey, “Beyond the Bedside: The ...

The round was led by Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds, and prominent angel investors from the Pacific Northwest. Gestalt Diagnostics, a leading innovator in ...

The new, versatile platform offers two configurations, a combined console (VCS) as well as a standalone cataract system (CS). This platform is designed to deliver superior efficiency for vitreoretinal ...

Lately, people have started to look at mental health in a much wider way, not just focusing on brain chemicals and medicines. Medication is still a big part of treatment… ...

"The EVSS represents a new paradigm in peripheral interventions," said Christopher Haig, Co-Founder and CEO of Efemoral Medical. "It's easy to deploy, has high radial strength, can be made in longer ...

VERAXA Biotech’s majority shareholders are Xlife Sciences AG (SIX: XLS), a Swiss-based publicly listed life science incubator fund, the European Molecular Biology Laboratory ("EMBL"), and its ...

The new, versatile platform offers two configurations, a combined console (VCS) as well as a standalone cataract system (CS). This platform is designed to deliver superior efficiency for vitreoretinal ...

Collaboration will deliver innovative AI-powered pathology tools and quality control enhancements to accelerate clinical trials and biomarker discovery. Continue ReadingPrecision for Medicine and ...

The Series B-1 warrants will have an exercise price of $0.85 per share, will be immediately exercisable and will expire 5 years from issuance. The Series B-2 warrants will have an exercise price of $0 ...

Continue ReadingSecond Phase of ADVANTAGE AF study of FARAPULSE ™ Pulsed Field Ablation System Meets Primary Safety and Efficacy Endpoints ...

Collaboration will deliver innovative AI-powered pathology tools and quality control enhancements to accelerate clinical trials and biomarker discovery. Precision for Medicine, a leading provider of ...